[go: up one dir, main page]

FI943596A7 - Method for preparing therapeutically useful macrolide compounds - Google Patents

Method for preparing therapeutically useful macrolide compounds

Info

Publication number
FI943596A7
FI943596A7 FI943596A FI943596A FI943596A7 FI 943596 A7 FI943596 A7 FI 943596A7 FI 943596 A FI943596 A FI 943596A FI 943596 A FI943596 A FI 943596A FI 943596 A7 FI943596 A7 FI 943596A7
Authority
FI
Finland
Prior art keywords
macrolide compounds
therapeutically useful
group
preparing therapeutically
hydroxyl group
Prior art date
Application number
FI943596A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI100402B (en
FI943596A0 (en
Inventor
John Barrie Ward
Hazel Mary Noble
Neil Porter
Richard Alan Fletton
David Noble
Derek Ronald Sutherland
Michael Vincent John Ramsay
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858522692A external-priority patent/GB8522692D0/en
Priority claimed from GB858522695A external-priority patent/GB8522695D0/en
Priority claimed from FI864150A external-priority patent/FI100025B/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to FI943596A priority Critical patent/FI100402B/en
Publication of FI943596A7 publication Critical patent/FI943596A7/en
Publication of FI943596A0 publication Critical patent/FI943596A0/en
Application granted granted Critical
Publication of FI100402B publication Critical patent/FI100402B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to the preparation of novel macrolide compounds of the formula (I) and salts thereof, in which formula R1 is methyl, ethyl or isopropyl, R2 is hydrogen or OR5, with OR5 being a hydroxyl group or a substituted hydroxyl group having at most 25 carbon atoms, and R3 is hydrogen, or R2 and R3 form, together with the carbon atom to which they are bonded, the group > C=O, and OR4 denotes the same as OR5, provided that, when R2 is a hydroxyl group, OR4 is then not a hydroxyl or methoxy group. These compounds possess an antibiotic effect. <IMAGE>
FI943596A 1985-09-13 1994-08-02 Process for the preparation of therapeutically useful macrolide compounds FI100402B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI943596A FI100402B (en) 1985-09-13 1994-08-02 Process for the preparation of therapeutically useful macrolide compounds

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8522695 1985-09-13
GB8522692 1985-09-13
GB858522692A GB8522692D0 (en) 1985-09-13 1985-09-13 Chemical compounds
GB858522695A GB8522695D0 (en) 1985-09-13 1985-09-13 Chemical compounds
FI864150A FI100025B (en) 1985-09-13 1986-10-14 Process for the preparation of therapeutically useful macrolide compounds
FI864150 1986-10-14
FI943596A FI100402B (en) 1985-09-13 1994-08-02 Process for the preparation of therapeutically useful macrolide compounds
FI943596 1994-08-02

Publications (3)

Publication Number Publication Date
FI943596A7 true FI943596A7 (en) 1994-08-02
FI943596A0 FI943596A0 (en) 1994-08-02
FI100402B FI100402B (en) 1997-11-28

Family

ID=27444117

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943596A FI100402B (en) 1985-09-13 1994-08-02 Process for the preparation of therapeutically useful macrolide compounds

Country Status (1)

Country Link
FI (1) FI100402B (en)

Also Published As

Publication number Publication date
FI100402B (en) 1997-11-28
FI943596A0 (en) 1994-08-02

Similar Documents

Publication Publication Date Title
ES9000023A1 (en) Macrolide antibiotics and their preparation
NO823836L (en) PROCEDURE FOR THE PREPARATION OF ANTIFIBRINOLYTIC ACTIVE COMPOUNDS.
AU548974B2 (en) Oligoglucoside derivatives
IE800669L (en) Cephalosporins.
EP0339671A3 (en) Derivative of caffeic acid and pharmaceutical composition containing the same
DK288686A (en) PHARMACEUTICAL PREPARATIONS
NO157438C (en) PROCEDURE FOR THE MANUFACTURING OF BLAKING SLOW CONTROL OR ADJUSTMENT SERUM.
NO174848C (en) Analogous Process for Preparing Therapeutically Active Substitutes
ES8506731A1 (en) Cephalosporin derivatives.
SE8303719D0 (en) NOVEL EBURNANE OXIME DERIVATIVES AND PROCESS FOR PREPARING SAME
GB2017087A (en) Process for the preparation of xanthone derivatives
ES8403129A1 (en) PROCEDURE FOR THE PREPARATION OF NEW SUBSTITUTED TIENOBENZODIAZEPINONES.
FI943596A7 (en) Method for preparing therapeutically useful macrolide compounds
GB2005246A (en) beta -Lactam compounds and processes for their preparation
AU564235B2 (en) 3-heterocyclicthiomethy-cephen compounds
ES8200648A2 (en) Ionic polyiodo benzene derivatives useful as X-ray contrast media
YU158385A (en) Process for obtaining derivatives of 2-pyridine thioles
SE8004621L (en) benzimidazole derivative
ES435361A1 (en) 2-Methyl-1-(substituted)phenyl-2-propyl esters of 2-aminopropanoic acid
DE3363575D1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
SE8302452D0 (en) METHOD FOR TREATMENT OF SENILE DEMENTIA
DK481883A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE DERIVATIVES
ES2077345T3 (en) INTERMEDIARIES OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND USE.
GB2017103A (en) Cephalosporin analogues
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them